Cargando…
Injectable, macroporous scaffolds for delivery of therapeutic genes to the injured spinal cord
Biomaterials are being developed as therapeutics for spinal cord injury (SCI) that can stabilize and bridge acute lesions and mediate the delivery of transgenes, providing a localized and sustained reservoir of regenerative factors. For clinical use, direct injection of biomaterial scaffolds is pref...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AIP Publishing LLC
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7946441/ https://www.ncbi.nlm.nih.gov/pubmed/33728392 http://dx.doi.org/10.1063/5.0035291 |
_version_ | 1783663051254267904 |
---|---|
author | Ehsanipour, Arshia Sathialingam, Mayilone Rad, Laila M. de Rutte, Joseph Bierman, Rebecca D. Liang, Jesse Xiao, Weikun Di Carlo, Dino Seidlits, Stephanie K. |
author_facet | Ehsanipour, Arshia Sathialingam, Mayilone Rad, Laila M. de Rutte, Joseph Bierman, Rebecca D. Liang, Jesse Xiao, Weikun Di Carlo, Dino Seidlits, Stephanie K. |
author_sort | Ehsanipour, Arshia |
collection | PubMed |
description | Biomaterials are being developed as therapeutics for spinal cord injury (SCI) that can stabilize and bridge acute lesions and mediate the delivery of transgenes, providing a localized and sustained reservoir of regenerative factors. For clinical use, direct injection of biomaterial scaffolds is preferred to enable conformation to unique lesions and minimize tissue damage. While an interconnected network of cell-sized macropores is necessary for rapid host cell infiltration into—and thus integration of host tissue with—implanted scaffolds, injectable biomaterials have generally suffered from a lack of control over the macrostructure. As genetic vectors have short lifetimes in vivo, rapid host cell infiltration into scaffolds is a prerequisite for efficient biomaterial-mediated delivery of transgenes. We present scaffolds that can be injected and assembled in situ from hyaluronic acid (HA)-based, spherical microparticles to form scaffolds with a network of macropores (∼10 μm). The results demonstrate that addition of regularly sized macropores to traditional hydrogel scaffolds, which have nanopores (∼10 nm), significantly increases the expression of locally delivered transgene to the spinal cord after a thoracic injury. Maximal cell and axon infiltration into scaffolds was observed in scaffolds with more regularly sized macropores. The delivery of lentiviral vectors encoding the brain-derived neurotrophic factor (BDNF), but not neurotrophin-3, from these scaffolds further increased total numbers and myelination of infiltrating axons. Modest improvements to the hindlimb function were observed with BDNF delivery. The results demonstrate the utility of macroporous and injectable HA scaffolds as a platform for localized gene therapies after SCI. |
format | Online Article Text |
id | pubmed-7946441 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | AIP Publishing LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-79464412021-03-15 Injectable, macroporous scaffolds for delivery of therapeutic genes to the injured spinal cord Ehsanipour, Arshia Sathialingam, Mayilone Rad, Laila M. de Rutte, Joseph Bierman, Rebecca D. Liang, Jesse Xiao, Weikun Di Carlo, Dino Seidlits, Stephanie K. APL Bioeng Articles Biomaterials are being developed as therapeutics for spinal cord injury (SCI) that can stabilize and bridge acute lesions and mediate the delivery of transgenes, providing a localized and sustained reservoir of regenerative factors. For clinical use, direct injection of biomaterial scaffolds is preferred to enable conformation to unique lesions and minimize tissue damage. While an interconnected network of cell-sized macropores is necessary for rapid host cell infiltration into—and thus integration of host tissue with—implanted scaffolds, injectable biomaterials have generally suffered from a lack of control over the macrostructure. As genetic vectors have short lifetimes in vivo, rapid host cell infiltration into scaffolds is a prerequisite for efficient biomaterial-mediated delivery of transgenes. We present scaffolds that can be injected and assembled in situ from hyaluronic acid (HA)-based, spherical microparticles to form scaffolds with a network of macropores (∼10 μm). The results demonstrate that addition of regularly sized macropores to traditional hydrogel scaffolds, which have nanopores (∼10 nm), significantly increases the expression of locally delivered transgene to the spinal cord after a thoracic injury. Maximal cell and axon infiltration into scaffolds was observed in scaffolds with more regularly sized macropores. The delivery of lentiviral vectors encoding the brain-derived neurotrophic factor (BDNF), but not neurotrophin-3, from these scaffolds further increased total numbers and myelination of infiltrating axons. Modest improvements to the hindlimb function were observed with BDNF delivery. The results demonstrate the utility of macroporous and injectable HA scaffolds as a platform for localized gene therapies after SCI. AIP Publishing LLC 2021-03-09 /pmc/articles/PMC7946441/ /pubmed/33728392 http://dx.doi.org/10.1063/5.0035291 Text en © Author(s). 2473-2877/2021/5(1)/016104/18 All article content, except where otherwise noted, is licensed under a Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Articles Ehsanipour, Arshia Sathialingam, Mayilone Rad, Laila M. de Rutte, Joseph Bierman, Rebecca D. Liang, Jesse Xiao, Weikun Di Carlo, Dino Seidlits, Stephanie K. Injectable, macroporous scaffolds for delivery of therapeutic genes to the injured spinal cord |
title | Injectable, macroporous scaffolds for delivery of therapeutic genes to the injured spinal cord |
title_full | Injectable, macroporous scaffolds for delivery of therapeutic genes to the injured spinal cord |
title_fullStr | Injectable, macroporous scaffolds for delivery of therapeutic genes to the injured spinal cord |
title_full_unstemmed | Injectable, macroporous scaffolds for delivery of therapeutic genes to the injured spinal cord |
title_short | Injectable, macroporous scaffolds for delivery of therapeutic genes to the injured spinal cord |
title_sort | injectable, macroporous scaffolds for delivery of therapeutic genes to the injured spinal cord |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7946441/ https://www.ncbi.nlm.nih.gov/pubmed/33728392 http://dx.doi.org/10.1063/5.0035291 |
work_keys_str_mv | AT ehsanipourarshia injectablemacroporousscaffoldsfordeliveryoftherapeuticgenestotheinjuredspinalcord AT sathialingammayilone injectablemacroporousscaffoldsfordeliveryoftherapeuticgenestotheinjuredspinalcord AT radlailam injectablemacroporousscaffoldsfordeliveryoftherapeuticgenestotheinjuredspinalcord AT deruttejoseph injectablemacroporousscaffoldsfordeliveryoftherapeuticgenestotheinjuredspinalcord AT biermanrebeccad injectablemacroporousscaffoldsfordeliveryoftherapeuticgenestotheinjuredspinalcord AT liangjesse injectablemacroporousscaffoldsfordeliveryoftherapeuticgenestotheinjuredspinalcord AT xiaoweikun injectablemacroporousscaffoldsfordeliveryoftherapeuticgenestotheinjuredspinalcord AT dicarlodino injectablemacroporousscaffoldsfordeliveryoftherapeuticgenestotheinjuredspinalcord AT seidlitsstephaniek injectablemacroporousscaffoldsfordeliveryoftherapeuticgenestotheinjuredspinalcord |